(MedPage Today) — Two commonly used mucoactive agents leaned toward more harm than benefit for critically ill patients with acute respiratory failure, according to the open-label randomized MARCH trial.
In people with acute respiratory failure…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
